Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Dechra Pharmaceuticals Plc LSE:DPH London Ordinary Share GB0009633180 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -12.00 -0.34% 3,510.00 3,500.00 3,506.00 3,570.00 3,482.00 3,524.00 235,082 16:35:04
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 515.1 40.9 32.9 106.8 3,802

Dechra Pharmaceuticals PLC Director/PDMR Shareholding

23/09/2020 3:19pm

UK Regulatory (RNS & others)


Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart


From Aug 2020 to Oct 2020

Click Here for more Dechra Pharmaceuticals Charts.

TIDMDPH

RNS Number : 9157Z

Dechra Pharmaceuticals PLC

23 September 2020

23 September 2020

Dechra(R) Pharmaceuticals PLC

(Dechra or the Company)

Notification and public disclosure of transactions by

persons discharging managerial responsibilities (PDMRs)

Dechra Pharmaceuticals PLC announces that on 21 September 2020, the following PDMRs exercised nil cost options over ordinary shares of 1p each in the Company. The options were granted to them on 2 March 2018 pursuant to the Dechra Pharmaceuticals PLC Long Term Incentive Plan (the LTIP). The exercise of the options was subject to the achievement of performance conditions which were satisfied to the extent that the options vested at 73.7%. Ian Page and Tony Griffin sold sufficient shares (acquired pursuant to the exercise) in order to fund the resulting tax liability. In accordance with the Company's Directors' Remuneration Policy, the remaining shares must be retained for a period of two years from the date of vesting.

 
 Name            Capacity    Options      Shares Sold  Sale Price    Total beneficial   Percentage 
                              Exercised                 per share     shareholding       of issued 
                                                                      following this     share capital 
                                                                      announcement 
 Ian Page        Director    29,409      13,864        GBP31.48220   638,919            0.591% 
 Tony Griffin    Director    8,916       4,472         GBP31.48220   75,050             0.069% 
 

In connection with the exercise, Ian Page's tax qualifying option over 1,197 shares granted on 2 March 2018 at an exercise price of GBP25.06 lapsed.

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Forms

 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                                Ian Page 
     ----------------------------------  --------------------------------------- 
 2.   Reason for the notification 
     --------------------------------------------------------------------------- 
 a)   Position/status                     Director/PDMR 
     ----------------------------------  --------------------------------------- 
 b)   Initial notification/               Initial Notification 
       amendment 
     ----------------------------------  --------------------------------------- 
 3.   Details of the Issuer 
     --------------------------------------------------------------------------- 
 a)   Name                                Dechra Pharmaceuticals PLC 
     ----------------------------------  --------------------------------------- 
 b)   LEI code                            213800J4UVB5OWG8VX82 
     ----------------------------------  --------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     --------------------------------------------------------------------------- 
 a)   Description of                      Ordinary Shares of 1 pence each 
       the financial 
       instrument 
                                           ISIN: GB0009633180 
       Identification 
       code 
     ----------------------------------  --------------------------------------- 
 b)   Nature of the                       Exercise of 29,409 options under the 
       transaction                         Company's Long Term Incentive Plan 
     ----------------------------------  --------------------------------------- 
 c)   Price(s) and volumes(s)             Price(s)                Volume(s) 
                                           GBPNil Cost             29,409 
     ----------------------------------  ----------------------  --------------- 
 d)        Aggregated information 
             *    Aggregate volume 
                                            N/A 
 
             *    Price 
     ----------------------------------  --------------------------------------- 
 e)   Date of the transaction             2020.09.21 
     ----------------------------------  --------------------------------------- 
 f)   Place of the transaction            Outside a trading venue 
     ----------------------------------  --------------------------------------- 
 
 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                                Ian Page 
     ----------------------------------  ------------------------------------------ 
 2.   Reason for the notification 
     ------------------------------------------------------------------------------ 
 a)   Position/status                     Director/PDMR 
     ----------------------------------  ------------------------------------------ 
 b)   Initial notification/               Initial Notification 
       amendment 
     ----------------------------------  ------------------------------------------ 
 3.   Details of the Issuer 
     ------------------------------------------------------------------------------ 
 a)   Name                                Dechra Pharmaceuticals PLC 
     ----------------------------------  ------------------------------------------ 
 b)   LEI code                            213800J4UVB5OWG8VX82 
     ----------------------------------  ------------------------------------------ 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     ------------------------------------------------------------------------------ 
 a)   Description of                      Ordinary Shares of 1 pence each 
       the financial 
       instrument 
                                           ISIN: GB0009633180 
       Identification 
       code 
     ----------------------------------  ------------------------------------------ 
 b)   Nature of the                       Partial sale of shares obtained under 
       transaction                         the Company's Long Term Incentive Plan 
                                           to satisfy tax liability 
     ----------------------------------  ------------------------------------------ 
 c)   Price(s) and volumes(s)             Price(s)                  Volume(s) 
                                           GBP 31.4822               13,864 
     ----------------------------------  ------------------------  ---------------- 
 d)        Aggregated information 
             *    Aggregate volume          13,864 
 
                                            GBP 31.4822 
             *    Price                     GBP436,469.22 
 
 
             *    Total 
     ----------------------------------  ------------------------------------------ 
 e)   Date of the transaction             2020.09.22 
     ----------------------------------  ------------------------------------------ 
 f)   Place of the transaction            London Stock Exchange 
     ----------------------------------  ------------------------------------------ 
 
 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                                   Tony Griffin 
     -------------------------------------  -------------------------------------- 
 2.   Reason for the notification 
     ----------------------------------------------------------------------------- 
 a)   Position/status                        Director/PDMR 
     -------------------------------------  -------------------------------------- 
 b)   Initial notification/                  Initial Notification 
       amendment 
     -------------------------------------  -------------------------------------- 
 3.   Details of the Issuer 
     ----------------------------------------------------------------------------- 
 a)   Name                                   Dechra Pharmaceuticals PLC 
     -------------------------------------  -------------------------------------- 
 b)   LEI code                               213800J4UVB5OWG8VX82 
     -------------------------------------  -------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     ----------------------------------------------------------------------------- 
 a)   Description of                         Ordinary Shares of 1 pence each 
       the financial 
       instrument 
                                              ISIN: GB0009633180 
       Identification 
       code 
     -------------------------------------  -------------------------------------- 
 b)   Nature of the                          Exercise of 8,916 options under the 
       transaction                            Company's Long Term Incentive Plan 
     -------------------------------------  -------------------------------------- 
 c)   Price(s) and volumes(s)                Price(s)            Volume(s) 
                                              GBPnil              8,916 
     -------------------------------------  ------------------  ------------------ 
 d)        Aggregated information 
             *    Aggregate volume 
                                               N/A 
 
             *    Price 
     -------------------------------------  -------------------------------------- 
 e)   Date of the transaction                2020.09.21 
     -------------------------------------  -------------------------------------- 
 f)   Place of the transaction               Outside a trading venue 
     -------------------------------------  -------------------------------------- 
 
 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                                 Tony Griffin 
     -----------------------------------  ---------------------------------------------- 
 2.   Reason for the notification 
     ----------------------------------------------------------------------------------- 
 a)   Position/status                      Director/PDMR 
     -----------------------------------  ---------------------------------------------- 
 b)   Initial notification/                Initial Notification 
       amendment 
     -----------------------------------  ---------------------------------------------- 
 3.   Details of the Issuer 
     ----------------------------------------------------------------------------------- 
 a)   Name                                 Dechra Pharmaceuticals PLC 
     -----------------------------------  ---------------------------------------------- 
 b)   LEI code                             213800J4UVB5OWG8VX82 
     -----------------------------------  ---------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     ----------------------------------------------------------------------------------- 
 a)   Description of                       Ordinary Shares of 1 pence each 
       the financial 
       instrument 
                                            ISIN: GB0009633180 
       Identification 
       code 
     -----------------------------------  ---------------------------------------------- 
 b)   Nature of the                        Sale of shares obtained under the Company's 
       transaction                          Long Term Incentive Plan . 
     -----------------------------------  ---------------------------------------------- 
 c)   Price(s) and volumes(s)              Price(s)                   Volume(s) 
                                            GBP31.4822                 4,472 
     -----------------------------------  -------------------------  ------------------- 
 d)        Aggregated information 
             *    Aggregate volume           4,472 
 
                                             GBP 31.4822 
             *    Price                      GBP140,788.40 
 
 
             *    Total 
     -----------------------------------  ---------------------------------------------- 
 e)   Date of the transaction              2020.09.22 
     -----------------------------------  ---------------------------------------------- 
 f)   Place of the transaction             London Stock Exchange 
     -----------------------------------  ---------------------------------------------- 
 

For further information, please contact:

Melanie Hall, Company Secretary

Telephone number: 01606 814730

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHKKNBDQBKDFCB

(END) Dow Jones Newswires

September 23, 2020 10:19 ET (14:19 GMT)

1 Year Dechra Pharmaceuticals Chart

1 Year Dechra Pharmaceuticals Chart

1 Month Dechra Pharmaceuticals Chart

1 Month Dechra Pharmaceuticals Chart
ADVFN Advertorial
Your Recent History
LSE
DPH
Dechra Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201029 21:17:22